$DNTH news
The latest DNTH stock news: headlines, filings, AI summaries and sentiment for $DNTH, updated around the clock.
- Dianthus Therapeutics Reports Q3 GAAP EPS of -$0.81, Exceeding Estimates
- Dianthus Therapeutics, Inc. /DE/ - 10-Q Filing
- Dianthus Therapeutics, Inc. /DE/ - 8-K Filing
- Citi Initiates Buy Rating on Dianthus Therapeutics
- Dianthus Therapeutics Announces Equity Awards to New Employees
- Dianthus Therapeutics, Inc. /DE/ - 8-K Filing
- Dianthus Therapeutics Shares Rise 320% Year-to-Date Despite Major Stake Reduction by Octagon Capital Advisors
- Octagon Capital Advisors Reduces Stake in Dianthus Therapeutics Despite Strong Share Performance
- Dianthus Therapeutics CFO Sells 8,224 Shares for $739,000
- Dianthus Therapeutics CFO Sells All Direct Shares for $739,000